American International Group, Inc. Kaleido Biosciences, Inc. Transaction History

American International Group, Inc.

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.05 - $1.7 $480 - $16,350	-9,618 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$1.3 - $2.7 $878 - $1,825	-676 Reduced 6.57%	9,618 $16,000
Q4 2021 Feb 11, 2022	SELL	$2.39 - $6.02 $738 - $1,860	-309 Reduced 2.91%	10,294 $25,000
Q3 2021 Nov 12, 2021	SELL	$5.36 - $7.99 $1,345 - $2,005	-251 Reduced 2.31%	10,603 $58,000
Q2 2021 Aug 13, 2021	BUY	$5.82 - $8.72 $16,837 - $25,226	2,893 Added 36.34%	10,854 $81,000
Q1 2021 May 07, 2021	BUY	$7.2 - $16.82 $8,193 - $19,141	1,138 Added 16.68%	7,961 $64,000
Q4 2020 Feb 12, 2021	SELL	$5.77 - $11.33 $646 - $1,268	-112 Reduced 1.61%	6,823 $62,000
Q3 2020 Nov 04, 2020	BUY	$5.09 - $11.07 $4,402 - $9,575	865 Added 14.25%	6,935 $77,000
Q2 2020 Aug 12, 2020	SELL	$4.62 - $8.01 $3,021 - $5,238	-654 Reduced 9.73%	6,070 $45,000
Q1 2020 May 04, 2020	SELL	$3.62 - $9.49 $1,411 - $3,701	-390 Reduced 5.48%	6,724 $41,000
Q4 2019 Feb 05, 2020	BUY	$5.02 - $8.87 $19,718 - $34,841	3,928 Added 123.29%	7,114 $36,000
Q3 2019 Nov 08, 2019	SELL	$6.74 - $11.3 $141 - $237	-21 Reduced 0.65%	3,186 $24,000
Q2 2019 Aug 13, 2019	BUY	$11.25 - $18.1 $36,078 - $58,046	3,207 New	3,207 $37,000

2.65K

Ticker KLDO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,622,600
Description
Kaleido Biosciences, Inc., a clinical-stage healthcare company, develops microbiome metabolic therapies. The company develops KB195 for the treatment of patients with urea cycle disorder; KB295 to treat ulcerative colitis; KB174 for the treatment of hepatic encephalopathy; and KB109 to treat COVID-19 disease. It also develops programs for the tr...

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

Stay updated on American International Group, Inc. with notifications on news.